Acute Leukemia and Myeloid Malignancies Rounds Philadelphia
May 22, 2025
Format
Live, In-Person Event
*Pre-registration required.
Interactive continuing medical education activity for healthcare professionals in Philadelphia, New Jersey, Delaware, and surrounding areas to discuss acute leukemia and myeloid malignancies updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with acute leukemia and myeloid malignancies.
Agenda
5:30 PM – Dinner and Networking
6:30 PM – Welcome and Overview of Program
Catherine Lai, MD, MPH
6:40 PM – Overview of LLS Resources
Ruby Nava-Ramos, MPH
6:45 PM – Case Presentation and Discussion on High-risk APL: Challenges and Clinical Decisions
Michael A. Brister, MD and Sheila De Young, DO
7:10 PM – Case Presentation and Discussion on Low-Intensity vs. High-Intensity Treatment for Young, Fit AML Patients
Gina Keiffer, MD and Tara Rakiewicz, MD
7:35 PM – Case Presentation and Discussion on Menin Inhibitors in KMT2A Rearranged Relapsed AML
Sara Small, MD, PhD and Christina Darwish, MD
8:00 PM – Case Presentation and Discussion on CAR T-cell Therapy for ALL
Noelle Frey, MD, MS and Matthew Connor, MD
8:25 PM – Panel discussion and wrap-up
All Faculty
8:30 PM – Conclusion
Catherine Lai, MD, MPH
Educational Objectives
At the conclusion of this activity, participants will be better able to:
- Explain the most recent data on novel treatment options in acute leukemias and myeloid malignancies
- Discuss drug interactions with novel therapies and how to manage
- Explain diagnostic and prognostic testing and challenges, relapse prevention and detection of measurable residual disease
- Explain disparities and challenges in the diagnosis and treatment of acute leukemias and myeloid malignancies
- Identify resources for patient education and support
Advisory Group
Catherine Lai, MD, MPH (Chair)
Hospital of the University of Pennsylvania
Philadelphia, PA
Katie Allen, CRNP
Hospital of the University of Pennsylvania
Philadelphia, PA
Alison Carulli, PharmD, BCOP
Hospital of the University of Pennsylvania
Philadelphia, PA
Margie Kasner, MD, MSCE
Sidney Kimmel Cancer Center
Thomas Jefferson University
Philadelphia, PA
Grace Shyu, PA-C
Hospital of the University of Pennsylvania
Philadelphia, PA
Michael Styler, MD
Fox Chase Cancer Center
Temple University
Philadelphia, PA
Faculty
Catherine Lai, MD, MPH (Chair)
Hospital of the University of Pennsylvania
Philadelphia, PA
Michael A. Brister, MD
Cooper University Health Care
Camden, NJ
Matthew Connor, MD
Hospital of the University of Pennsylvania
Philadelphia, PA
Christina Darwish, MD
Fox Chase Cancer Center
Temple University
Philadelphia, PA
Sheila De Young, DO
Cooper University Health Care
Camden, NJ
Noelle Frey, MD, MS
Hospital of the University of Pennsylvania
Philadelphia, PA
Gina Keiffer, MD
Sidney Kimmel Cancer Center
Thomas Jefferson University Hospital
Philadelphia, PA
Ruby Nava-Ramos, MPH
The Leukemia & Lymphoma Society
Washington, DC
Tara Rakiewicz, MD
Sidney Kimmel Cancer Center
Thomas Jefferson University Hospital
Philadelphia, PA
Sara Small, MD, PhD
Fox Chase Cancer Center
Temple University
Philadelphia, PA
Continuing Education Information
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute Inc and The Leukemia & Lymphoma Society. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hour through the California Board of Registered Nursing.
Pharmacy
Medical Learning Institute Inc designates this application-based continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-25-016-L01-P
For Pharmacists, Medical Learning Institute Inc will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form, and return it to staff at the end of the program. A certificate of completion will be emailed within 30 days of receipt. If you have questions regarding the receipt of your certificate, please contact us via email at ndane@mlieducation.org.
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supporters
Supported by educational grants from Autolus Therapeutics and Novartis Pharmaceuticals Corporation.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.